Find News

Filter articles

Applied Filters

Showing 11 to 20 of 730 results

Clarivate buys SequenceBase to expand life sciences expertise

US09-09-2019Sarah Morgan

IP services company Clarivate Analytics has acquired patent sequence information provider SequenceBase to expand its search and analysis capabilities for the life sciences IP market.

Lupin and Boehringer enter $720m anti-cancer drug partnership

Germany, India05-09-2019Sarah Morgan

Indian drugmaker Lupin and German pharma company Boehringer Ingelheim have formed an alliance to develop a therapy for patients with difficult-to-treat cancers.

LSIPR webinar: CAR-T trends show increased filing for narrower tech, says HGF partner

UK, US05-09-2019Saman Javed

CAR-T cells have achieved hugely-positive outcomes in treating forms of cancer that are otherwise difficult to treat.

Vertex to buy diabetes biotech firm for $950m

US04-09-2019Sarah Morgan

US-based Vertex Pharmaceuticals has announced it will pay $950 million to acquire Semma Therapeutics, a biotechnology company focused on researching a cure for Type 1 diabetes.

Gene-editing alliance releases bioethical framework

International03-09-2019Sarah Morgan

An alliance of companies that use gene-editing technologies has released a bioethical framework, as controversy over gene-editing continues.

Pinsent Masons hires Fieldfisher’s co-head of life sciences

UK03-09-2019Sarah Morgan

Nicole Jadeja, the former co-head of life sciences at Fieldfisher, has joined Pinsent Masons as a partner in its London office.

Ionis licenses chronic hepatitis B treatments to GSK

US28-08-2019Saman Javed

Biotech company Ionis Pharmaceuticals is to license its antisense medicines, used to treat people with chronic hepatitis B, to GlaxoSmithKline.

Jazz Pharma buys clinical-stage biotech company

Ireland14-08-2019Sarah Morgan

Ireland-based Jazz Pharma has acquired Virginia-based Cavion in a deal that values the clinical-stage biotech company at up to $312.5 million.

Bayer buys BlueRock to build cell therapy expertise

Germany, US09-08-2019Sarah Morgan

Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion.

NHS to receive £250m for new AI lab

UK08-08-2019Saman Javed

The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

Showing 11 to 20 of 730 results